Deal Expected In Insurer's Actos Cancer Suit Against Takeda
Dozens of claims from Blue Cross and Blue Shield of Massachusetts alleging that a link between diabetes treatment Actos and bladder cancer was long known to drug manufacturer Takeda are expected...To view the full article, register now.
Already a subscriber? Click here to view full article